We propose a new cancer cell mechanism for survival that is activated when the demand for segregating and eliminating ... 4T1 and IOMM-Lee cells were seeded into opaque-walled 96-well plates, at a ...

The targeting of protein phosphatases has been gaining attention as their role in cancer development and progression has been elucidated ... and Rosi melanoma (p = 0.0335) cell lines. Compound 2 ...

The FDA has granted breakthrough device designation to the ACR-368 OncoSignature assay for use in endometrial cancer. The OncoSignature multiplex immunofluorescence ... Secondary end points included ...

Trastuzumab Emtansine Improves Long-Term Survival ... Cancer Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

The drug sensitivity of four human cell lines was compared with that of Sarcoma 180 (of mouse origin) in an agar plate assay procedure. Significant differences in cell line response were found with ...

Credit: Thinkstock Investigators explored the potential of a noninvasive ctDNA assay as a predictive biomarker for advanced or metastatic urothelial cancer ... of total cell-free DNA (cfDNA ...

Endometrial cancer (EC) ranks as the second most prevalent gynecologic malignancy globally, with approximately 189,000 new ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

There is a growing need for innovative assays to study complex biological systems, as medical research continues to unveil novel pathways and targets for diseases such as autoimmune diseases, ...